Connect with us

Crowdfunding

[RealView Imaging in Israel Hayom] Israeli startup makes medical treatment using floating holograms a reality

Avatar

Published

on

Crowdfunding

The #1 Key to the Biggest Biotech Profits

Avatar

Published

on

As Wayne and I have been explaining recently, there’s one trend you absolutely need to be investing in right now:

Biotech.

Most investors avoid this lucrative sector because, frankly, it can seem overwhelming. “I’m not a doctor!” they say. “How am I supposed to predict which drugs will get FDA approval?”

So today, we’d like to point you to a specific biotech company you should own right now.

Why? Because in the next 45 days, it could realistically double.

But before I tell you more, let me explain why investing in biotech is so important right now.

Public and Private Investors Can’t Get Enough

As our partner Lou Basenese wrote yesterday:

“Being a profitable trend trader means following big money flows, no matter where they’re going. And today, the smart money is sprinting, faster than Usain Bolt, into biotech.”

Consider:

  • The SPDR S&P Biotech ETF (XBI) is up 78% since the March bottom. That trounces the returns of the Nasdaq (+64%) and the S&P 500 index (+44%) over the same time period.
  • Private capital is flooding into biotechs. During Q2 2020, venture funding into U.S.-based biotechs reached $6.4 billion. That’s the single highest quarterly total ever.
  • Public market investors can’t get enough, either. Case in point: 40% of all IPO and follow-on financings in the market this year have been for biotechs. In other words, the overwhelming majority of new money being put to work in the public market is going into biotech deals.

But even against this backdrop, I understand that you still might be worried about trying to pick individual biotech investments.

And that’s where some wisdom from Lou comes into the picture…

The #1 Key to the Biggest Biotech Profits

In a recent column for you, Lou shared a safe way to invest in the smallest and most innovative (and therefore, the most potentially profitable) biotech stocks…

You can do that via the Principal Healthcare Innovators Index ETF (BTEC).

BTEC remains a top choice today, and a safe choice.

However, as an ETF, it invests in a basket of stocks. Over 250 of them.

So, while its focus on biotech makes it possible for us to earn a market-beating return…

Because of its breadth, it’s impossible for us to maximize our profits.

To make the biggest returns — for example, to double or more our money — we need to focus on individual biotech stocks.

And that’s where Lou’s live event comes into the picture…

“Buy this Biotech Stock!”

You see, last night at 8pm Eastern, Lou hosted a LIVE online event on Zoom.

During the event, Lou taught his readers how to take the guesswork out of biotech investing…

And furthermore, he shared — also, 100% free — the safest and most potentially profitable biotech stock to own right now.

As he explained, this biotech stock has already been de-risked:

  • Its drug works. In fact, it works so well that the FDA allowed the company to skip Phase 3 trials and go straight to applying for full marketing approval. If granted, this drug will be on the market next year.
  • An urgent need for it exists. Over 1 million people in the U.S. currently suffer from the disease it treats. Another 40,000 people each year develop it. And yet no other treatment option exists. Making matters even more urgent, most of the newly diagnosed patients are children.
  • A profit delivery date has been set. In 60 days or less, we’ll know if its drug application is complete and ready for final review. (Lou fully expects that it will be.) Then, the FDA will provide a specific date where it will issue a final approval. Anticipation of this decision alone could lead shares to double… and they could double again when approval is granted.

The Ticker Symbol of Lou’s #1 Biotech Stock

And now I’ve got some very good news to share…

Lou let us record his event for all of our Crowdability readers…

And now it’s ready for you to view »

As Lou wrote before he went live,

“No gimmicks here. During the event, I’ll be sharing the company’s name and ticker symbol, as well as my investment thesis for it.” 

Again, this is the identity of Lou’s #1 biotech stock to buy right now…

And he’d like to share it with you — for free.

To watch the replay of Lou’s live event from last night, just click here »

Happy Investing.

Best Regards,
Matthew Milner
Matthew Milner
Founder
Crowdability.com

Comments

Source: http://www.crowdability.com/article/the-1-key-to-the-biggest-biotech-profits

Continue Reading

Crowdfunding

10 Reasons I’m Thankful…

Avatar

Published

on

With Thanksgiving upon us, I’m forgoing our regular content and financial analysis to count my blessings, Trend Trader Daily style.

As you’ll see, many of these blessings are still financial-related. Sorry, I can’t help it…

  • I’m thankful for my losing stock recommendations from the past, as they keep me humble and working harder to perfect my craft.
  • I’m thankful for all my winning stock recommendations. I imagine you are, too. (No explanation necessary.)
  • I’m thankful to live in the United States where I can practice any religion, speak my mind freely, and should I feel so inclined, own a gun.
  • I’m thankful that I work with a team that keeps their word and is committed to delivering quality, no matter how much time and effort it entails.
  • I’m thankful for the 1980s. It was the only era where we could dress up like clowns, or in fluorescent colored clothing, and be considered fashionable. Also: the music of that era is unbeatable. Disagree if you must, but there’s no changing my mind.
  • I’m thankful for new relationships (both business and personal), as they prove that the rewards for enduring dark days and bad relationships far outweigh the struggles.
  • I’m thankful I escaped growing up in New Jersey without having a heavy accent. Otherwise, my professional career might have been severely stunted. No offense to youse other guys that weren’t as lucky.
  • Speaking of New Jersey, I’m thankful for Joey’s House of Pizza in my current hometown of Nashville. There’s nothing like authentic northeast pizza to stir up the nostalgia of growing up in the greatest part of the country.
  • I’m thankful the investment markets are dynamic. It keeps my job exciting and unpredictable, and ensures that no one can maintain an unfair advantage for long.
  • I’m thankful for my many investing mentors — Warren Buffett, Peter Lynch, Sir John Templeton, David Dreman, James Bagwell, and Alexander Green, among others.
  • I’m thankful for forgiveness. Without it, I would never have been able to spend an unforgettable weekend with my estranged brother last year before his untimely passing.
  • I’m thankful for our loyal Trend Trader Daily readers. Without you, I’d be muzzled and working for a bulge bracket Wall Street firm.
  • Most important of all, I’m thankful for my family… and my three kids, in particular. Their innocent laughter always seems to take away my concerns, even if just for a moment.

In case you’re counting, I didn’t stop at 10 reasons.

That’s because, even in these strange Covid-19 times, there’s more to be thankful for than to bemoan.

Or as Henry David Thoreau wrote, “I am grateful for what I am and have. My thanksgiving is perpetual.”

So if you’re feeling thankful, too, here are two ways you could consider giving back.

Two Actions to Take Today

First, take a moment to count your own blessings. I’m confident a mere 60 seconds of reflection will overwhelm you with gratitude.

Second, if I’ve ever done something to help make you money, make you laugh, or improve your financial wisdom, I’d ask that you consider joining me in donating to a very worthy cause:

The Roberto Clemente Santa Ana Health Clinic.

Located in Nicaragua, the second poorest country in the Western Hemisphere, the clinic provides free and low-cost medical care to over 30,000 patients in the isolated villages of Limon, Rancho Santana, and 27 surrounding communities.

Think prenatal care, basic prescriptions, treatment for asthma attacks and allergic reactions, and general checkups. Things we take for granted because walk-in clinics and hospitals abound in the United States.

Without the vision and passion of my friend and former boss, Julia Guth, the clinic would never have been built.

Here’s the thing. As a U.S.-based 501(c)(3) non-profit organization, the clinic depends solely on private donations to continue operating. And giving, particularly in developing countries, is down significantly this year. At a time when Nicaragua severely needs it, too.

You see, not only is the country suffering through the pandemic like the rest of the world, but Nicaragua was also hit with two devastating hurricanes.

I recognize that times remain tough, and that countless other causes deserve your attention and consideration. As a decade-long supporter of the clinic, though, I can personally attest that even small contributions will make an immediate difference.

I’ll be making a donation today. And I hope you’ll join me.

After all, as the playwright Thorton Wilder said, “Money is like manure; it’s not worth a thing unless it’s spread around encouraging young things to grow.”

To donate, click here.

And if you cannot or choose not to donate, no worries. I’m thankful for your consideration, and for the continued confidence you place in me as a reader of Trend Trader Daily.

As always, if you have any thoughts you’d like to share, don’t hesitate to contact us at info@trendtraderdaily.com.

I wish you and your family a very healthy, safe, and happy Thanksgiving… whether you’re celebrating with them in person, or from afar.

Ahead of the tape,
Lou Basenese
Lou Basenese

Comments

Source: http://www.crowdability.com/article/10-reasons-im-thankful

Continue Reading

Crowdfunding

The Safest Biotech Stock to Own Today

Avatar

Published

on

Consider this your last notice…

If there’s one trend you should be investing in right now besides semiconductors, it’s biotech!

Most investors avoid this lucrative sector because they believe there’s no reasonable way to predict which drugs will work in the clinic and/or get FDA approval.

But there is a way. And in a moment, I’ll prove it — and I’ll share details on a specific biotech you should own right now.

Not only do I believe this is the safest biotech stock to own today, but in the next 45 days, I believe it could realistically double.

But before I tell you more, let me show you what’s propelling this red-hot biotech trend…

Public and Private Investors Can’t Get Enough

Being a profitable trend trader means following big money flows, no matter where they’re going.

And today, the smart money is sprinting, faster than Usain Bolt, into biotech.

Consider:

  • The SPDR S&P Biotech ETF (XBI) is up a staggering 78% since the March bottom. That trounces the returns of the Nasdaq (+64%) and the S&P 500 index (+44%) over the same time period. (As I alluded to earlier, only semiconductors have performed so well.)
  • A tsunami of private capital is flooding into biotechs. During the second quarter of 2020, venture funding into U.S.-based biotechs checked in at a whopping $6.4 billion. That’s the single highest quarterly total ever.
  • Public market investors can’t get enough, either. Case in point: 40% of all IPO and follow-on financings in the market this year have been for biotechs. In other words, the overwhelming majority of new money being put to work in the public market is going into biotech deals.

But even against this backdrop, I know some of you are still afraid to try and pick individual biotech investments.

And that’s why I’ve got you covered (you can thank me later!)…

The Key to Making the Biggest Returns

In a recent column for you, I shared a safe way to invest in the smallest and most innovative (and therefore, the most potentially profitable) biotech stocks…

You can do that via the Principal Healthcare Innovators Index ETF (BTEC).

BTEC remains a top choice today, and a safe choice.

However, as an ETF, it invests in a basket of stocks. Over 250 of them.

So, while its focus on biotech makes it possible for us to earn a market-beating return…

Because of its breadth, it’s impossible for us to maximize our profits.

To make the biggest returns — for example, to double or more our money — we need to focus on individual biotech stocks.

And that’s what my live event tonight is all about…

Myth-Busting Biotech Investing

At 8pm Eastern tonight, I’ll be hosting a fully live online event…

What you’ll learn during this FREE event will help you take all the guesswork out of biotech investing…

And furthermore, I’ll be sharing — also, 100% free — the safest and most potentially profitable biotech stock to own right now.

No gimmicks here. During the event, I’ll be sharing the company’s name and ticker symbol, as well as my investment thesis for it.

That alone is reason enough to register here and tune in live.

And as you’ll learn tonight, this biotech stock is anything but risky.

  • Its drug works. In fact, it works so well that the FDA allowed the company to skip Phase 3 trials and go straight to applying for full marketing approval. If granted, this drug will be on the market next year.
  • An urgent need exists for the drug. Over 1 million people in the U.S. currently suffer from the disease it treats. Another 40,000 people each year develop it. And yet no other treatment option exists. Making matters even more urgent, most of the newly diagnosed patients are children.
  • A profit delivery date is set. In 60 days or less, we’ll know if its drug application is complete and ready for final review. I fully expect it will be. Then, the FDA will provide a specific date where it will issue a final approval. Anticipation of this decision alone could lead shares to double… and they could double again when approval is granted.

Bottom line: You no longer have an excuse to miss out on the red-hot biotech trend.

Either invest in the BTEC ETF…

Join my free event tonight to find out the identity of my top biotech stock to buy right now…

Or even better, do both! Your portfolio will thank you later.

Ahead of the tape,
Lou Basenese
Lou Basenese

Comments

Source: http://www.crowdability.com/article/the-safest-biotech-stock-to-own-today

Continue Reading

Crowdfunding

Friday Charts: Why Stocks Love Jobs and I Hate Zoom

Avatar

Published

on

When Friday rolls around, we roll out the charts in the Trend Trader Daily Nation.

After all, a picture is supposed to be worth a thousand words. So we figure, why not embrace it?

This week, we’re serving up a timely snapshot on unemployment and one work from home stock that’s (finally) showing signs of imploding.

Are you brave enough to step up and short it?

Take a look and be sure to let us know what you think!

Stocks Love Jobs

The latest news out of the Labor Department on the unemployment front hardly has anyone singing.

Initial jobless claims have been hovering around 1 million for weeks. Normally, we want to see that number south of 350,000 claims.

But we’re not living in normal times. So we have to reset our levels and focus more on the trend.

And the trend is undeniable. Take a look:

We’re way down from the peak of around 5 million claims in the early days of the pandemic.

Here’s the thing — stocks love jobs. In fact, the relationship between initial jobless claims and the S&P 500 is undeniable.

As claims go down, stocks go up (and vice versa).

This strong inverse relationship is one of my favorite leading indicators. So if you’re trying to figure out where stocks are headed next, look no further than weekly initial jobless claims.

Zoomsgiving and Bust

I’m so damn tired of Zoom calls and the crazy disconnect in valuation and market size for the company behind the technology, Zoom Video Communications, Inc. (ZM).

I won’t bore you with my reasons for the former, but the latter couldn’t be more straightforward.

IDC estimates the entire market for video conferencing will hit $43 billion. In 2022, mind you.

And yet, Zoom’s stock is currently trading at a market cap of just over $125 billion.

In other words, the valuation is fully baked and then some, as Zoom only has a fraction of that market size in current sales.

It appears investors are finally waking up to this reality, too — even as the company tries to encourage more and more usage by offering no time limit on calls over Thanksgiving, since so many families will opt for virtual get-togethers.

The stock’s down 25% from its all-time high, dropping below support at the 50-day moving average.

But there’s way more room for shares to fall.

If you have the stones to short it, now would be an ideal entry. If you’re a tad more risk-sensitive, consider some cheap put options expiring in January or June 2022.

By then, the coronavirus will be gone — and so will all the unnecessary Zoom calls. Can’t wait!

Ahead of the tape,
Lou Basenese
Lou Basenese

Comments

Source: http://www.crowdability.com/article/friday-charts-why-stocks-love-jobs-and-i-hate-zoom

Continue Reading
Energy9 hours ago

Ballard Closes US$402.5 Million Bought Deal Offering of Common Shares

Energy9 hours ago

Lithium-ion Battery Market Size USD 129.3 Billion By 2027 At A CAGR of 18.0% | Valuates Reports

Energy9 hours ago

CBAK Energy and Kandi Group Signed Supply Framework Agreement

Energy10 hours ago

Level Sensors Market worth $6.1 billion by 2025 – Exclusive Report by MarketsandMarkets™

Energy10 hours ago

Rescheduling of Work Commitments in Corentyne Block, Guyana

Cyber Security11 hours ago

Technological Innovations at the Tokyo Olympics

Gaming15 hours ago

The Basics: Popular Casino Games You Should Play

Press Releases15 hours ago

The International Vaccine Institute Supports a Global Campaign to Reduce the Spread of Covid-19

Esports16 hours ago

T1 re-signs top laner Canna, extends contract until 2022

Energy16 hours ago

JinkoSolar to Report Third Quarter 2020 Results on December 7, 2020

Energy16 hours ago

EWPG Holding AB: Interim report for the period 1 January – 30 September 2020

Esports18 hours ago

Khan joins DAMWON as team’s new top laner

Cyber Security18 hours ago

Different ways tech plays a key role in securing igaming platforms

Energy22 hours ago

LONGi suministra 273MW de sus módulos solares a la mayor planta solar del Sureste de Asia

Ecommerce24 hours ago

ADvendio Celebrates 10 Years of Product Excellence and Growth

Esports24 hours ago

Super Smash Bros. Melee Slippi mod launches broadcast feature early in response to #FreeMelee

Esports24 hours ago

The 7 best low-back gaming chairs

Denmark
Esports1 day ago

Heroic move past Endpoint in BLAST Premier Showdown

Esports1 day ago

Na’Vi brings Mag back from inactive roster to coach Dota 2 team

Esports1 day ago

Fantasy games live for DreamHack Masters Winter and Flashpoint 2 playoffs

Energy1 day ago

Worldwide Hybrid Diesel Genset Industry to 2026 – Key Drivers and Restraints

Energy1 day ago

The Neutrino Energy Group Transcends the Theoretical to Transform Practical Energy Use Worldwide

Esports1 day ago

How to activate crossplay on Rainbow Six Siege

Esports1 day ago

Pokémon teases 25th-anniversary celebration during Macy’s Thanksgiving Day Parade

Energy1 day ago

ChemPoint es seleccionado como distribuidor de los productos de Soluciones Especializadas de DuPont para México

Esports1 day ago

Apex Legends Dev Believes Wattson Isn’t ‘Useless’

Esports1 day ago

Horizon Voice Actor Shows What it Was Like to Record During the Pandemic

United States
Esports1 day ago

Liquid edge past MAD Lions in BLAST Premier Fall Showdown

Energy1 day ago

Europe Excavator Market Outlook Report 2020-2025 Featuring Prominent Players – Caterpillar, CNH, John Deere, Kobelco, Liebherr

Esports1 day ago

League’s original 17 champions and how different they were 11 years ago

Trending